| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.048 | 0.8 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |